RU2007147376A - 2,8-DIMETHYL-5 [2- (4-R-phenyl) -ethyl] -1,2,3,4-tetrahydro-1H-pyrido [4,3-b] INDOLES - MEDICINAL SUBSTANCE, PHARMACEUTICAL COMPOSITION, METHODS THEIR RECEIVING AND APPLICATIONS FOR TREATMENT OF ANXIETY DISORDERS - Google Patents
2,8-DIMETHYL-5 [2- (4-R-phenyl) -ethyl] -1,2,3,4-tetrahydro-1H-pyrido [4,3-b] INDOLES - MEDICINAL SUBSTANCE, PHARMACEUTICAL COMPOSITION, METHODS THEIR RECEIVING AND APPLICATIONS FOR TREATMENT OF ANXIETY DISORDERS Download PDFInfo
- Publication number
- RU2007147376A RU2007147376A RU2007147376/04A RU2007147376A RU2007147376A RU 2007147376 A RU2007147376 A RU 2007147376A RU 2007147376/04 A RU2007147376/04 A RU 2007147376/04A RU 2007147376 A RU2007147376 A RU 2007147376A RU 2007147376 A RU2007147376 A RU 2007147376A
- Authority
- RU
- Russia
- Prior art keywords
- pharmaceutical composition
- anxiety disorders
- drug
- drug substance
- anxiety
- Prior art date
Links
- ZVHJJCGNCQFSSA-UHFFFAOYSA-O Cc1ccc(CC[n]2c3ccc(C)cc3c3c2CC[NH2+]C3)cc1 Chemical compound Cc1ccc(CC[n]2c3ccc(C)cc3c3c2CC[NH2+]C3)cc1 ZVHJJCGNCQFSSA-UHFFFAOYSA-O 0.000 description 1
Abstract
1. Лекарственные субстанции (анксиолитики), обладающие нейротропной активностью по отношению к α-адреноцепторам, допаминовым D и серотониновым рецепторам ЦНС, общей формулы 1 в виде свободных оснований или в виде фармацевтически приемлемых солей и/или гидратов для фармацевтических композиций и готовых лекарственных форм, предназначенные для лечения и предупреждения тревожных расстройств. ! ! где R представляет собой атом водорода или низший алкил. ! 2. Лекарственные субстанции по п.1, представляющие собой 2,8-диметил-5-фенетил-1,2,3,4-тетрагидро-1Н-пиридо[4,3-b]индол 1.1 или его гидрохлорид 1.2, 2,8-диметил-5-[2-(4-метилфенил)-этил]-1,2,3,4-тетрагидро-1Н-пиридо[4,3-b]индол 1.3 или его гидрохлорид 1.4. ! ! 3. Фармацевтическая композиция с широким спектром рецепторспецифичной активности для лечения и/или предупреждения развития тревожных расстройств людей и теплокровных животных, содержащая фармацевтически эффективное количество лекарственной субстанции общей формулы 1 по п.1. ! 4. Фармацевтическая композиция по п.3, содержащая фармацевтически эффективное количество лекарственной субстанции по п.2. ! 5. Способ получения фармацевтической композиции по п.3 или 4 смешением с инертным наполнителем и/или растворителем, по крайней мере, одной лекарственной субстанции общей формулы 1 или ее фармацевтически приемлемой соли. ! 6. Лекарственный препарат в форме таблеток, капсул или инъекций, помещенных в фармацевтически приемлемую упаковку, включающий в свой состав лекарственную субстанцию по любому из пп.1, 2 или новую фармацевтическую композицию по любому из пп.3, 4, предназначенный для лечения и/или предупреждения тревожных расстройств. ! 7. Лекарстве1. Medicinal substances (anxiolytics) with neurotropic activity against α-adrenoceptors, dopamine D and central nervous system serotonin receptors, of the general formula 1 in the form of free bases or in the form of pharmaceutically acceptable salts and / or hydrates for pharmaceutical compositions and finished dosage forms, designed to treat and prevent anxiety disorders. ! ! where R represents a hydrogen atom or lower alkyl. ! 2. The drug substances according to claim 1, which are 2,8-dimethyl-5-phenethyl-1,2,3,4-tetrahydro-1H-pyrido [4,3-b] indole 1.1 or its hydrochloride 1.2, 2, 8-dimethyl-5- [2- (4-methylphenyl) ethyl] -1,2,3,4-tetrahydro-1H-pyrido [4,3-b] indole 1.3 or its hydrochloride 1.4. ! ! 3. A pharmaceutical composition with a wide range of receptor-specific activity for treating and / or preventing the development of anxiety disorders in humans and warm-blooded animals, comprising a pharmaceutically effective amount of a drug substance of the general formula 1 according to claim 1. ! 4. The pharmaceutical composition according to claim 3, containing a pharmaceutically effective amount of a drug substance according to claim 2. ! 5. A method for producing a pharmaceutical composition according to claim 3 or 4 by mixing with an inert excipient and / or solvent of at least one drug substance of general formula 1 or a pharmaceutically acceptable salt thereof. ! 6. A drug in the form of tablets, capsules or injections, placed in a pharmaceutically acceptable package, comprising a drug substance according to any one of claims 1, 2 or a new pharmaceutical composition according to any one of claims 3, 4, intended for treatment and / or prevention of anxiety disorders. ! 7. The medicine
Claims (8)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2007147376/04A RU2007147376A (en) | 2007-12-21 | 2007-12-21 | 2,8-DIMETHYL-5 [2- (4-R-phenyl) -ethyl] -1,2,3,4-tetrahydro-1H-pyrido [4,3-b] INDOLES - MEDICINAL SUBSTANCE, PHARMACEUTICAL COMPOSITION, METHODS THEIR RECEIVING AND APPLICATIONS FOR TREATMENT OF ANXIETY DISORDERS |
PCT/RU2008/000780 WO2009082268A2 (en) | 2007-12-21 | 2008-12-19 | LIGANDS OF α-ADRENOCEPTORS AND OF DOPAMINE, HISTAMINE, IMIDAZOLINE AND SEROTONIN RECEPTORS AND THE USE THEREOF |
JP2010539344A JP2011507835A (en) | 2007-12-21 | 2008-12-19 | Alpha-adrenergic receptor, dopamine, histamine, imidazoline and serotonin receptor ligands and uses thereof |
EP08864305A EP2236511A4 (en) | 2007-12-21 | 2008-12-19 | Ligands of alpha-adrenoceptors and of dopamine, histamine, imidazoline and serotonin receptors and the use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2007147376/04A RU2007147376A (en) | 2007-12-21 | 2007-12-21 | 2,8-DIMETHYL-5 [2- (4-R-phenyl) -ethyl] -1,2,3,4-tetrahydro-1H-pyrido [4,3-b] INDOLES - MEDICINAL SUBSTANCE, PHARMACEUTICAL COMPOSITION, METHODS THEIR RECEIVING AND APPLICATIONS FOR TREATMENT OF ANXIETY DISORDERS |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2008150397/04A Substitution RU2407744C2 (en) | 2008-12-19 | 2008-12-19 | Ligands of alpha-adrenoceptors, dopamine, histamine, imidazoline and serotonin receptors and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2007147376A true RU2007147376A (en) | 2009-06-27 |
Family
ID=41026644
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2007147376/04A RU2007147376A (en) | 2007-12-21 | 2007-12-21 | 2,8-DIMETHYL-5 [2- (4-R-phenyl) -ethyl] -1,2,3,4-tetrahydro-1H-pyrido [4,3-b] INDOLES - MEDICINAL SUBSTANCE, PHARMACEUTICAL COMPOSITION, METHODS THEIR RECEIVING AND APPLICATIONS FOR TREATMENT OF ANXIETY DISORDERS |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2007147376A (en) |
-
2007
- 2007-12-21 RU RU2007147376/04A patent/RU2007147376A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI426906B (en) | Pharmaceutical compositions for treating schizophrenia | |
CN104519878A (en) | Esketamine for treatment of treatment-refractory or treatment-resistant depression | |
DK2164572T4 (en) | Carbamoyl-cyclohexanes FOR THE TREATMENT OF ACUTE MANI | |
CN106456629A (en) | Vmat2 inhibitors for the treatment of hyperkinetic movement disorders | |
EA017443B1 (en) | Tetrahydroquinoline derivatives for treating post-traumatic stress disorders | |
RU2661618C1 (en) | Nephopam suppositories for the treatment of acute and chronic pain syndrome on a lipophilic basis and the method for their preparation | |
RU2011146032A (en) | 5-HT4 RECEPTOR AGON COMPOUNDS FOR TREATMENT OF COGNITIVE DISORDERS | |
KR20150067168A (en) | Nootropic compositions for improving memory performances | |
CA3069462A1 (en) | Ambroxol to improve and/or extend healthspan, lifespan and/or mental acuity | |
RU2509560C1 (en) | New therapeutic combinations of mirtazapine applicable in pain conditions | |
Hess et al. | Experience with a naphthylmedetomidine–ketamine–hyaluronidase combination in inducing immobilization in anthropoid apes | |
JP2009502898A (en) | Therapeutic use of nefopam | |
RU2007147376A (en) | 2,8-DIMETHYL-5 [2- (4-R-phenyl) -ethyl] -1,2,3,4-tetrahydro-1H-pyrido [4,3-b] INDOLES - MEDICINAL SUBSTANCE, PHARMACEUTICAL COMPOSITION, METHODS THEIR RECEIVING AND APPLICATIONS FOR TREATMENT OF ANXIETY DISORDERS | |
AU2013224831B2 (en) | Use of modafinil in the treatment of cocaine addicts | |
CN106176748A (en) | Norisoboidine purposes in preparing anti-depression drug | |
Waheed et al. | Tramadol and its health implications | |
Darabi et al. | Ketamine has no pre-emptive analgesic effect in children undergoing inguinal hernia repair | |
US20120232025A1 (en) | Safener drug combinations for use with nmda antagonist drugs | |
AU2013214223B2 (en) | (1r,4r)-6'-Fluoro-(N-methyl- or N,N-dimethyl-)-4-phenyl-4',9'-dihydro-3'H-spiro-[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for treating fibromyalgia and chronic fatigue syndrome | |
RU2007147358A (en) | 2,8-DIMETHYL-5- [2- (4-R-phenyl) -ethyl] -1,2,3,4-tetrahydro-1H-pyrido [4,3-b] ligands of ligands of dopamine receptors and their use | |
CN1418099A (en) | Choice compound for treatment of fibromyalgia and chronic fatigue syndrome | |
RU2007147374A (en) | 2,8-DIMETHYL-5- [2- (4-R-Phenyl) -ethyl] -1,2,3,4-tetrahydro-1H-pyrido [4,3-b] INDOLES - MEDICAL SUBSTANCE, PHARMACEUTICAL COMPOSITION, METHODS FOR THEIR OBTAINING AND APPLICATION FOR TREATMENT OF DEPRESSIONS | |
RU2007147363A (en) | 2,8-DIMETHYL-5- [2- (4-R-phenyl) -ethyl] -1,2,3,4-tetrahydro-1H-pyrido [4,3-b] ligands of serotonin 5-nt7 receptors AND THEIR APPLICATION AND OBTAINING | |
JP5195418B2 (en) | Functional brain disease treatment | |
RU2007147349A (en) | SUBSTITUTED 1,2,3,4-TETRAHYDRO-1H-PYRIDO [4,3-b] INDOLES AND 1,2,3,4,5,6-HEXAHYDRO-AZEPINO [4,3-b] INDOLES-MEDICINAL SUBSTANCE, PHARMACEUTICAL COMPOSITION, WAYS OF ITS OBTAINING AND APPLICATION FOR TREATMENT OF ANXIETY DISORDERS |